Zevra Therapeutics, Inc. ZVRA Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s software and technology licenses, net?
- Zevra Therapeutics, Inc. (ZVRA) reported software and technology licenses, net of $143K in Q1 2026.
- How has Zevra Therapeutics, Inc.'s software and technology licenses, net changed year-over-year?
- Zevra Therapeutics, Inc.'s software and technology licenses, net decreased by 51.2% year-over-year, from $293K to $143K.
- What is the long-term trend for Zevra Therapeutics, Inc.'s software and technology licenses, net?
- Over 5 years (2020 to 2025), Zevra Therapeutics, Inc.'s software and technology licenses, net has grown at a -20.1% compound annual growth rate (CAGR), from $438K to $143K.